Core Scientific Statistics
Total Valuation
Core Scientific has a market cap or net worth of $5.39 billion. The enterprise value is $5.89 billion.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Core Scientific has 307.36 million shares outstanding. The number of shares has increased by 5.11% in one year.
| Current Share Class | 307.36M |
| Shares Outstanding | 307.36M |
| Shares Change (YoY) | +5.11% |
| Shares Change (QoQ) | +0.88% |
| Owned by Insiders (%) | 1.44% |
| Owned by Institutions (%) | 85.21% |
| Float | 279.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 249.72 |
| PS Ratio | 15.24 |
| Forward PS | 8.07 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 411.23 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.79
| Current Ratio | 1.79 |
| Quick Ratio | 1.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.74% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -10.44% |
| Revenue Per Employee | $1.07M |
| Profits Per Employee | -$1.83M |
| Employee Count | 325 |
| Asset Turnover | 0.25 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Core Scientific has paid $872,000 in taxes.
| Income Tax | 872,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.71% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +41.71% |
| 50-Day Moving Average | 15.23 |
| 200-Day Moving Average | 12.31 |
| Relative Strength Index (RSI) | 61.92 |
| Average Volume (20 Days) | 11,806,402 |
Short Selling Information
The latest short interest is 55.46 million, so 18.04% of the outstanding shares have been sold short.
| Short Interest | 55.46M |
| Short Previous Month | 56.59M |
| Short % of Shares Out | 18.04% |
| Short % of Float | 19.82% |
| Short Ratio (days to cover) | 3.57 |
Income Statement
In the last 12 months, Core Scientific had revenue of $348.43 million and -$595.22 million in losses. Loss per share was -$1.92.
| Revenue | 348.43M |
| Gross Profit | 30.07M |
| Operating Income | -147.81M |
| Pretax Income | -1.08B |
| Net Income | -595.22M |
| EBITDA | -54.59M |
| EBIT | -147.81M |
| Loss Per Share | -$1.92 |
Full Income StatementBalance Sheet
The company has $581.35 million in cash and $1.16 billion in debt, giving a net cash position of -$581.12 million or -$1.89 per share.
| Cash & Cash Equivalents | 581.35M |
| Total Debt | 1.16B |
| Net Cash | -581.12M |
| Net Cash Per Share | -$1.89 |
| Equity (Book Value) | -1.06B |
| Book Value Per Share | -3.51 |
| Working Capital | 442.04M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $12.92 million and capital expenditures -$269.63 million, giving a free cash flow of -$256.71 million.
| Operating Cash Flow | 12.92M |
| Capital Expenditures | -269.63M |
| Free Cash Flow | -256.71M |
| FCF Per Share | -$0.84 |
Full Cash Flow StatementMargins
| Gross Margin | 8.63% |
| Operating Margin | -42.42% |
| Pretax Margin | -308.82% |
| Profit Margin | n/a |
| EBITDA Margin | -15.67% |
| EBIT Margin | -42.42% |
| FCF Margin | n/a |
Dividends & Yields
Core Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.11% |
| Shareholder Yield | -5.11% |
| Earnings Yield | -11.20% |
| FCF Yield | -4.83% |
Analyst Forecast
The average price target for Core Scientific is $19.08, which is 8.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $19.08 |
| Price Target Difference | 8.84% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 33.83% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Core Scientific has an Altman Z-Score of -2.08 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.08 |
| Piotroski F-Score | 3 |
